DiagnaMed Holdings Introduces Cervai Brain Health AI Solution

DiagnaMed Holdings Corp announced the pilot launch of Cervai, a world-first consumer brain health and wellness AI solution that aims to 'raise a red flag' for potential brain health issues by estimating brain age and providing a brain health score...

Cabinet Nods Memoranda on Health products with Netherlands and Others

The Union Cabinet has adopted separate memoranda with Ecuador, the Dominican Republic, and the Netherlands regarding cooperation in the area of medicinal product regulation. The three Memorandums of Understanding (MoU) signed by the Central Drugs...

Takeda's Hyqvia Bags US FDA Nod for Maintenance Therapy in Adults

Takeda announced that Hyqvia [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] has been approved by the US Food and Drug Administration (FDA) for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP)...

US FDA Nods Vertex's Casgevy To Treat Transfusion-dependent Beta Thalassemia

Vertex Pharmaceuticals Incorporated has announced that Casgevy, a CRISPR/Cas9 gene-edited cell therapy, has been approved by the US Food and Drug Administration (FDA) for the treatment of transfusion-dependent beta thalassemia (TDT) in patients...

GSK Introduces Vaccination Awareness Campaign For Children

GlaxoSmithKline Pharmaceuticals Limited initiated a multichannel campaign to raise awareness about immunizations, which give important protection to children aged one to two years. The Indian Academy of Paediatrics (IAP) recommends seven...

Sun Pharma To Acquire Remaining Stake in Taro for About USD 348 Million

Sun Pharmaceutical Industries Limited of India has announced that it will purchase all of Taro Pharmaceutical Industries' outstanding shares for $43 per share in cash, effectively assuming complete control of the company. Pharma's offer amounts...

Sun Pharma and Bayer Sign Pact To Sell Drug For Chronic Kidney Disease

Sun Pharma announced a collaboration with Bayer to market a medication for the treatment of chronic kidney disease and other conditions. Under the terms of the deal, Bayer granted Sun Pharma non-exclusive rights to market and distribute a second...

Roche Bags Marketing Nod from European Commission For Tecentriq SC

Roche announced that the European Commission has granted marketing authorisation for Tecentriq SC (atezolizumab), the European Union (EU)’s first PD-(L) cancer immunotherapy for subcutaneous (under the skin) injection. Last year, more than 38,000...

Parexel and JFCR Ink Pact To Advance Access To Oncology Clinical Trials

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, and the Japanese Foundation for Cancer Research (JFCR), the first and leading non-profit cancer...

Covid Vaccine Corbevax Secures WHO's Emergency Use Listing

The World Health Organization (WHO) has approved Corbevax, a Covid vaccine created by Hyderabad-based vaccine producer Biological E. Corbevax, India's first indigenously manufactured Covid-19 vaccine based on a protein subunit platform, is part...

© 2025 India Pharma Outlook. All Rights Reserved.